Salem Investment Counselors Inc Axogen, Inc. Transaction History

Salem Investment Counselors Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$8.8 - $16.0 $68,640 - $124,800	-7,800 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$10.62 - $13.12 $82,836 - $102,336	7,800 New	7,800 $91,000
Q2 2019 Aug 14, 2019	SELL	$18.5 - $25.47 $68,450 - $94,239	-3,700 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$14.62 - $22.13 $54,094 - $81,881	3,700 New	3,700 $136,000
Q4 2018 Feb 15, 2019	SELL	$17.09 - $38.25 $63,233 - $141,525	-3,700 Closed	0 $0
Q2 2018 Aug 15, 2018	SELL	$36.15 - $52.5 $32,535 - $47,250	-900 Reduced 19.57%	3,700 $186,000
Q1 2018 May 15, 2018	SELL	$24.4 - $40.25 $19,520 - $32,200	-800 Reduced 14.81%	4,600 $166,000
Q4 2017 Feb 16, 2018	SELL	$18.5 - $28.6 $11,100 - $17,160	-600 Reduced 10.0%	5,400 $153,000
Q3 2017 Nov 16, 2017	BUY	$14.65 - $19.35 $87,900 - $116,100	6,000	6,000 $113,000

162

36.6M

230K

400

Ticker AXGN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 42,283,700
Market Cap $697M
Description
AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...

Get notified when there are updates to the investment portfolio of Salem Investment Counselors Inc, based on Form 13F filings with the SEC.

Stay updated on Salem Investment Counselors Inc with notifications on news.